Imazodan hydrochloride

TargetMol
Product Code: TAR-T27596
Supplier: TargetMol
CodeSizePrice
TAR-T27596-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27596-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27596-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Imazodan hydrochloride, a potent and selective type III phosphodiesterase inhibitor, is used for the treatment of chronic congestive heart failure.
CAS:
89198-09-4
Formula:
C13H13ClN4O
Molecular Weight:
276.72
Purity:
0.98
SMILES:
Cl.O=C1CCC(=NN1)c1ccc(cc1)-n1ccnc1

References

1. Goldberg AD, Nicklas J, Goldstein S. Effectiveness of imazodan for treatment of chronic congestive heart failure. The Imazodan Research Group. Am J Cardiol. 1991 Sep 1;68(6):631-6. PubMed PMID: 1715125. 2. Allert JA, Adams HR. Inotropic and chronotropic profile of MCI-154: comparison with isoproterenol and imazodan in guinea pig cardiac preparations. J Cardiovasc Pharmacol. 1990 Jul;16(1):59-67. PubMed PMID: 1696667. 3. Jiang YY, Long K, Sheng ML. [Effects of imazodan and dazoxiben on cAMP levels and PGI2 production in cultured bovine aortic endothelial cells]. Zhongguo Yao Li Xue Bao. 1989 Sep;10(5):421-4. Chinese. PubMed PMID: 2559580. 4. Weishaar RE, Kobylarz-Singer D, Klinkefus BA. New mechanisms for positive inotropic agents: focus on the discovery and development of imazodan. Cardiovasc Drugs Ther. 1989 Mar;3(1):29-42. Review. PubMed PMID: 2487522.